Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blood Products Payment Rate Freeze Preferable To Proposed Cuts – Panel

This article was originally published in The Gray Sheet

Executive Summary

The APC Advisory Panel recommends that CMS freeze ambulatory payment classification rates for blood products at the 2003 hospital OPPS levels for 2004 and 2005, preventing payment rates from facing a 10% decrease under the 2004 proposed rule

You may also be interested in...



APC Floor Will Not Be Applied To Devices, But C-Codes Are Back – OPPS Rule

The payment rates for five device-related APCs will be raised from their 2004 proposed rates through the use of external data, but CMS will not apply a dampening mechanism for APCs falling in excess of 5%, according to the 12004 OPPS final rule

APC Floor Will Not Be Applied To Devices, But C-Codes Are Back – OPPS Rule

The payment rates for five device-related APCs will be raised from their 2004 proposed rates through the use of external data, but CMS will not apply a dampening mechanism for APCs falling in excess of 5%, according to the 12004 OPPS final rule

OPPS Stability Requires 5% Floor In Cuts To Device APCs – AdvaMed, MDMA

With 17 device-related APCs facing at least a 50% payment reduction from their 2002 rates, AdvaMed is asserting the need for a 5% floor on reductions in the 2004 hospital OPPS final rule

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel